Tumor glycolysis as a target for cancer therapy: progress and prospects.
about
Intrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and FunctionThe sweet trap in tumors: aerobic glycolysis and potential targets for therapyMolecular magnetic resonance imaging in cancerReviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer TherapyTargeted Therapies in Adult B-Cell MalignanciesBreaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer TherapyApplication of metabolomics in drug resistant breast cancer researchRedox control of glutamine utilization in cancerAntagonizing Bcl-2 family members sensitizes neuroblastoma and Ewing's sarcoma to an inhibitor of glutamine metabolism3D microtumors in vitro supported by perfused vascular networks.ROS homeostasis and metabolism: a critical liaison for cancer therapyA computational strategy to select optimized protein targets for drug development toward the control of cancer diseasesSubstrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scaleMethylglyoxal induces cell death through endoplasmic reticulum stress-associated ROS production and mitochondrial dysfunction.Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cellsEmerging Role of the Pentose Phosphate Pathway in Hepatocellular Carcinoma.Identification of Epigallocatechin-3- Gallate as an Inhibitor of Phosphoglycerate Mutase 1.Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.MICU1 drives glycolysis and chemoresistance in ovarian cancer.Dengue virus induces and requires glycolysis for optimal replicationMetabolic perturbation sensitizes human breast cancer to NK cell-mediated cytotoxicity by increasing the expression of MHC class I chain-related A/BMonocarboxylate transporter 1 inhibitors as potential anticancer agentsA weighty problem: metabolic perturbations and the obesity-cancer link.Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt LymphomaDrug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory.Functional expression of sodium-glucose transporters in cancer.Interventions to Slow Aging in Humans: Are We Ready?Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling.Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?Disruption of glycolytic flux is a signal for inflammasome signaling and pyroptotic cell deathA Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer CellsInhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling StepsGenetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancerJolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis.ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose.
P2860
Q26749556-816AF0FD-0B0B-481B-809F-02BFF90B20B3Q26766079-406FD5BC-F2DF-4F6C-BAF0-F93F907FCB14Q26782151-64BE7E0B-F53D-4AF9-A51E-78010EF2820DQ26783189-CF156649-E7F5-4536-8ABE-ED57179C9BAAQ26783195-B8549BF8-F806-4C67-A747-CB15716ADC76Q26784055-914C7870-B457-41EB-952F-8EC82370F367Q26866291-2EA77E6B-68CF-40F0-AA95-06DC65C4890DQ27005615-826D88C5-5246-4337-AE8D-9CF35190AF91Q27316754-EDBE64FA-9D91-426F-BD7F-746D743EEBF7Q27317186-87C42DAB-3A7C-4480-A395-C1AE6D259A15Q28080316-6EB418F6-40F4-40A6-8DC7-ED23880259FFQ28543105-5A5A570B-A397-4382-B2D2-C50CFA11DD41Q30042971-30200126-9EA8-4307-85B3-212A3E74B8DEQ30389325-FB97A6B0-0D53-4042-991B-84784298F853Q33598925-3BDC3B30-37BC-42DB-9DFB-F87B011576B3Q33618935-A10EC600-9907-4025-988A-8242D3A6E430Q33648885-28500466-DC1C-4AC3-8B99-47FAE3CEA4BDQ33658666-EF91CF63-FAAE-4A5A-B2AA-8903EE4C4017Q33736706-F4DD6A56-C417-4598-844B-E5B32D8CC4FCQ33779169-020A321D-3036-43EC-B836-B664331AE6B9Q33815720-EBF12684-3DC9-4866-85A8-A83F36D2E3F7Q35115662-B7EA1193-5646-47A3-9728-B0C7D7782AA7Q35506699-6F4F8176-A0C7-4758-A450-708AE1A92A00Q35615147-8BC05347-E922-44A0-B0AE-2BD560A1EFF4Q35689545-E23BD4AB-E00F-4D0B-AEB2-7E2BCDCC3256Q35696506-A863ED28-FDC0-4E75-A863-2741E79D1377Q35906092-2BD5E8C8-E1FA-4D26-B794-E8652D33E499Q35909986-82393E52-EC15-4B18-B7F7-5CFDCC87404DQ35935123-BFD08205-3E3B-4287-8A89-ECDB38562347Q35989618-D8881BB5-D014-47E8-8D9B-FA588BA89D87Q36254983-7E0D0568-1770-40CE-92F7-0FB5ED4E8487Q36561571-58127DB4-C891-45AE-A7F7-16E597EE8C5CQ36562175-4812128D-4F05-4F16-A65B-49BBB44C37E4Q36687966-88C0E68C-CBF4-437F-B20B-57EA6E07C86CQ36839612-05DCA8C9-F483-46F4-B0C4-EB57C1B0B0E9Q37163899-56AE1667-F7A8-4BD6-B8BD-AA80C8F77181Q37277390-C94E968E-2FFC-45CA-BA69-EDB734BDAB39Q37355438-9BD702DC-9300-4113-AB76-E602BA97C12DQ37379488-0402FF23-12CC-4F76-A214-F544353620C0Q37412531-224A676C-1A10-4506-94A6-22A9647B57C1
P2860
Tumor glycolysis as a target for cancer therapy: progress and prospects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tumor glycolysis as a target for cancer therapy: progress and prospects.
@en
type
label
Tumor glycolysis as a target for cancer therapy: progress and prospects.
@en
prefLabel
Tumor glycolysis as a target for cancer therapy: progress and prospects.
@en
P2860
P356
P1433
P1476
Tumor glycolysis as a target for cancer therapy: progress and prospects.
@en
P2093
Jean-Francois H Geschwind
Shanmugasundaram Ganapathy-Kanniappan
P2860
P2888
P356
10.1186/1476-4598-12-152
P5008
P577
2013-12-03T00:00:00Z
P5875
P6179
1000889241